Cochrane: This review attempted to evaluate the efficacy and safety of baclofen as a therapy for alcohol withdrawal syndrome (AWS). The evidence for recommending baclofen for AWS is insufficient. In recent years, baclofen has demonstrated potential to reduce
symptoms of severe AWS in people with alcoholism. Treatment with
baclofen is easy to manage, without producing any obvious side effects.
